登录 | 注册    关注公众号  
微信公众号
搜索
 >  Kits>CD47 >EP-138

CD47 [Biotinylated] : SIRP alpha Inhibitor Screening ELISA Kit

For research use only.

IDComponentsSize
EP138-C01High-bind Plate1plate
EP138-C02Human SIRP alpha15μg
EP138-C03Biotinylated Human CD4710μg
EP138-C04Anti-CD47 Neutralizing Antibody20μg
EP138-C05Streptavidin-HRP10μg
EP138-C06Coating Buffer12mL
EP138-C0710xWashing Buffer 50mL
EP138-C08Blocking Buffer50mL
EP138-C09Substrate Solution12mL
EP138-C10Stop Solution12mL

背景(Background)

CD47 is a transmembrane protein, a cell surface glycoprotein molecule belonging to the immunoglobulin superfamily that binds to a variety of proteins, including integrins, thrombospondin 1, and signal regulatory protein-α (SIRPα). In recent years, accumulating data have demonstrated that the CD47-SIRP-α axis is a key immune checkpoint in different cancers, including hematological malignancies, similar to PD-1/PD-L1 in solid tumors. Cd47-sirpα blockade has become a next-generation immune checkpoint blocking strategy for various malignancies after PD-1/PD-L1.

应用说明(Application)

This kit is developed for screening for inhibitors of human CD47 binding to human SIRP alpha.

It is for research use only.

重构方法(Reconstitution)

Please see Certificate of Analysis for details of reconstitution instruction and specific concentration.

存储(Storage)

Unopened kit should be stored at 2°C -8°C upon receiving. Find the expiration date on the outside packaging and do not use reagents past their expiration date.

The opened kit should be stored per components table. The shelf life is 30 days from the date of opening.

原理(Assay Principles)

This inhibitor screening ELISA kit is designed to facilitate the identification and characterization of new CD47 pathway inhibitors. The assay takes advantage of our in house-developed binding of biotinylated human CD47 to immobilized human SIRP alpha in a functional ELISA assay, and employs a simple colorimetric ELISA platform. Briefly, we provide you with a human Biotinylated CD47 protein, a human SIRP alpha protein, an anti-CD47 neutralizing antibody (as method verified Std.), and Streptavidin-HRP reagent.

Your experiment will include 4 simple steps:

a) Coat the plate with human SIRP alpha.

b) Add your molecule of interest to the tests.

c) Add human CD47-Biotin to bind the coated SIRP alpha.

d) Add Streptavidin-HRP followed by TMB or other colorimetric HRP substrate.

Finally, the half maximal inhibitory concentration (IC50) of your compound to CD47: SIRP alpha binding will be determined by comparing OD readings among different experimental groups.

 

典型数据-Typical Data Please refer to DS document for The assay protocol.

CD47 TYPICAL DATA

INHIBITION OF CD47[Biotinylated]: SIRP alpha BINDING BY ANTI-CD47 NEUTRALIZING ANTIBODY
Serial dilutions of Anti-CD47 Neutralizing antibody (Catalog # EP138-C04) (1:1 serial dilution, from 10 μg/mL to 0.01μg/mL) was added into Biotinylated CD47: SIRP alpha binding reactions. The assay was performed according to the protocol described below. Background was subtracted from data points prior to log transformation and curve fitting (QC tested).

 

前沿进展

 
 
货号/价格
文档
联系电话:
+86 400-682-2521(全国)
010-53681107(北京)
021-50850665(上海)
运输方式
订单邮箱:
order.cn@acrobiosystems.com
技术支持邮箱:
tech.cn@acrobiosystems.com
CD47靶点信息
英文全称:Cluster of differentiation 47
中文全称:分化群47
种类:Homo sapiens
上市药物数量:0详情
临床药物数量:55详情
最高研发阶段:临床三期
查看更多信息
前沿进展
点击查看详细
相关产品
View All CD47

消息提示

请输入您的联系方式,再点击提交!

确定